2,119 research outputs found

    Two-gluon form factor of the nucleon and J/ψJ/\psi photoproduction

    Full text link
    We argue that the t-dependence of the two-gluon form factor of the nucleon should be given by Γ(t)=(1t/m2g2)2\Gamma(t)=(1-t/m_{2g}^2)^{-2} with m2g21GeV2m_{2g}^2\approx 1 GeV^2. We demonstrate that this form provides a good description of the t-dependence of the cross section of the elastic photoproduction of J/ψJ/\psi-mesons between the threshold region of Eγ=11GeVE_{\gamma}=11 GeV (Cornell), Eγ=19GeVE_{\gamma}=19 GeV (SLAC) and Eγ=100GeVE_{\gamma}=100 GeV (FNAL) including the strong energy dependence of the t-slope. It is also well matched with the recent HERA data. The same assumption explains also the t-dependence of ϕ\phi-meson electroproduction near threshold at W=2.3GeV,Q2=1.0GeV2W=2.3 GeV, Q^2=1.0 GeV^2.Comment: 10 pages, 4 figure

    Recent results in relativistic heavy ion collisions: from ``a new state of matter'' to "the perfect fluid"

    Full text link
    Experimental Physics with Relativistic Heavy Ions dates from 1992 when a beam of 197Au of energy greater than 10A GeV/c first became available at the Alternating Gradient Synchrotron (AGS) at Brookhaven National Laboratory (BNL) soon followed in 1994 by a 208Pb beam of 158A GeV/c at the Super Proton Synchrotron (SPS) at CERN (European Center for Nuclear Research). Previous pioneering measurements at the Berkeley Bevalac in the late 1970's and early 1980's were at much lower bombarding energies (~ 1 A GeV/c) where nuclear breakup rather than particle production is the dominant inelastic process in A+A collisions. More recently, starting in 2000, the Relativistic Heavy Ion Collider (RHIC) at BNL has produced head-on collisions of two 100A GeV beams of fully stripped Au ions, corresponding to nucleon-nucleon center-of-mass energy, sqrt(sNN)=200 GeV, total c.m. energy 200A GeV. The objective of this research program is to produce nuclear matter with extreme density and temperature, possibly resulting in a state of matter where the quarks and gluons normally confined inside individual nucleons (r < 1 fm) are free to act over distances an order of magnitude larger. Progress from the period 1992 to the present will be reviewed, with reference to previous results from light ion and proton-proton collisions where appropriate. Emphasis will be placed on the measurements which formed the basis for the announcements by the two major laboratories: "A new state of matter", by CERN on Feb 10, 2000 and "The perfect fluid", by BNL on April 19, 2005.Comment: 62 pages, 39 figures. Review article published in Reports on Progress in Physics on June 23, 2006. In this published version, mistakes, typographical errors, and citations have been corrected and a subsection has been adde

    Charmonium absorption by nucleons

    Get PDF
    J/ΨJ/\Psi dissociation in collisions with nucleons is studied within a boson exchange model and the energy dependence of the dissociation cross section is calculated from the threshold for ΛcDˉ\Lambda_c{\bar D} production to high energies. We illustrate the agreement of our results with calculations based on short distance QCD and Regge theory. The compatibility between our calculations and the data on J/ΨJ/\Psi photoproduction on a nucleon is discussed. We evaluate the elastic J/Ψ+NJ/\Psi{+}N cross section using a forward dispersion relation and demonstrate the overall agreement with the predictions from QCD sum rules. Our results are compatible with the phenomenological dissociation cross section evaluated from the experimental data on J/ΨJ/\Psi production from γ+A\gamma{+}A, p+Ap{+}A and A+AA{+}A collisions.Comment: 14 pages, revtex, including 13 figures, accepted for publication in Phys. Rev.

    The Italian Network for Tumor Biotherapy (NIBIT): Getting together to push the field forward

    Get PDF
    As for a consolidated tradition, the 5th annual meeting of the Italian Network for Cancer Biotherapy took place in the Certosa of Pontignano, a Tuscan monastery, on September 20–22, 2007. The congress gathered more than 40 Italian leading groups representing academia, biotechnology and pharmaceutical industry. Aim of the meeting was to share new advances in cancer bio-immunotherapy and to promote their swift translation from pre-clinical research to clinical applications. Several topics were covered including: a) molecular and cellular mechanisms of tumor escape; b) therapeutic antibodies and recombinant constructs; c) clinical trials up-date and new programs; d) National Cooperative Networks and their potential interactions; e) old and new times in cancer immunology, an "amarcord". Here, we report the main issues discussed during the meeting
    corecore